The risk or severity of adverse effects can be increased when midazolam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with meprobamate.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with tubocurarine.


The risk or severity of adverse effects can be increased when irbesartan is combined with diflunisal.


The risk or severity of adverse effects can be increased when Lurasidone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when thalidomide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Etidocaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when paramethasone is combined with edrophonium.


The risk or severity of adverse effects can be increased when diflunisal is combined with estrone.


The risk or severity of adverse effects can be increased when labetalol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with fluocinonide.


The risk or severity of adverse effects can be increased when benazepril is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Melatonin is combined with butamben.


The risk or severity of adverse effects can be increased when amphotericin b is combined with dipyridamole.


The risk or severity of adverse effects can be increased when nitrendipine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when clonidine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when clonidine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when clonidine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when methysergide is combined with betamethasone.


The risk or severity of adverse effects can be increased when methysergide is combined with chloramphenicol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with metolazone.


The risk or severity of adverse effects can be increased when methysergide is combined with teniposide.


The risk or severity of adverse effects can be increased when amobarbital is combined with scopolamine.


The risk or severity of adverse effects can be increased when methysergide is combined with Fosamprenavir.


The risk or severity of adverse effects can be increased when bromazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when flurazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when sulindac is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when barnidipine is combined with acebutolol.


The risk or severity of adverse effects can be increased when prilocaine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when flurazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when carprofen is combined with fenbufen.


The risk or severity of adverse effects can be increased when prilocaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with vigabatrin.


The risk or severity of adverse effects can be increased when tolazoline is combined with spironolactone.


The risk or severity of adverse effects can be increased when Flupentixol is combined with cetirizine.


The risk or severity of adverse effects can be increased when methysergide is combined with Zucapsaicin.


The risk or severity of adverse effects can be increased when Quinine is combined with prilocaine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with paroxetine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when barnidipine is combined with captopril.


The risk or severity of adverse effects can be increased when Masoprocol is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Masoprocol is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when promethazine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Melatonin.


The risk or severity of adverse effects can be increased when Articaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when morphine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when morphine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when isoflurane is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when morphine is combined with benzocaine.


The risk or severity of adverse effects can be increased when promazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when alprazolam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when alprazolam is combined with zotepine.


The risk or severity of adverse effects can be increased when cocaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when gabapentin is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when tiapride is combined with tizanidine.


The risk or severity of adverse effects can be increased when furazolidone is combined with moclobemide.


The risk or severity of adverse effects can be increased when diclofenac is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Pizotifen is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when mesalamine is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when apomorphine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when azelastine is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with clonazepam.


The risk or severity of adverse effects can be increased when LISURIDE is combined with nifedipine.


The risk or severity of adverse effects can be increased when azelastine is combined with fenbufen.


The risk or severity of adverse effects can be increased when LISURIDE is combined with miconazole.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with promethazine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with aspirin.


The risk or severity of adverse effects can be increased when acebutolol is combined with hydralazine.


The risk or severity of adverse effects can be increased when cocaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when minoxidil is combined with timolol.


The risk or severity of adverse effects can be increased when butalbital is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with methyldopa.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when bupivacaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when reserpine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when ramipril is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when enalapril is combined with furosemide.


The risk or severity of adverse effects can be increased when levorphanol is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when levorphanol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with theobromine.


The risk or severity of adverse effects can be increased when ondansetron is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with ethanol.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Mometasone.


The risk or severity of adverse effects can be increased when Fosphenytoin is combined with paroxetine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Droxicam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with flunarizine.


The risk or severity of adverse effects can be increased when ethanol is combined with phendimetrazine.


The risk or severity of adverse effects can be increased when prazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when etizolam is combined with efavirenz.


The risk or severity of adverse effects can be increased when thiothixene is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when trazodone is combined with Phenelzine.


The risk or severity of adverse effects can be increased when phenytoin is combined with prilocaine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when bromocriptine is combined with docetaxel.


The risk or severity of adverse effects can be increased when thalidomide is combined with methyldopa.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with labetalol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with phenytoin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Alvimopan.


The risk or severity of adverse effects can be increased when paramethasone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when thalidomide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when thalidomide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when nabumetone is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Spirapril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when nimesulide is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with halothane.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with thiamylal.


The risk or severity of adverse effects can be increased when Etomidate is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Flupentixol is combined with nitrazepam.


The risk or severity of adverse effects can be increased when cinnarizine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with oxprenolol.


The risk or severity of adverse effects can be increased when ondansetron is combined with clonazepam.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when procaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when procaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with quazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with vinblastine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with benzocaine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with flunisolide.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with sertraline.


The risk or severity of adverse effects can be increased when proparacaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with resveratrol.


The risk or severity of adverse effects can be increased when ILOPROST is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with medrysone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Salsalate.


The risk or severity of adverse effects can be increased when Tramadol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Melatonin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Pentolinium is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Nabilone is combined with hydralazine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Escitalopram.


The risk or severity of adverse effects can be increased when buspirone is combined with flurazepam.


The risk or severity of adverse effects can be increased when diclofenac is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Nabilone is combined with enalapril.


The risk or severity of adverse effects can be increased when D-mannitol is combined with hydralazine.


The risk or severity of adverse effects can be increased when fluocinonide is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Metipranolol is combined with nicotine.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when sevoflurane is combined with valsartan.


The risk or severity of adverse effects can be increased when loxapine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with ramipril.


The risk or severity of adverse effects can be increased when methoxamine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when methoxamine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when loxapine is combined with maprotiline.


The risk or severity of adverse effects can be increased when ethopropazine is combined with tolterodine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when dopamine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when dopamine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with edrophonium.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Droxicam.


The risk or severity of adverse effects can be increased when salicylamide is combined with formestane.


The risk or severity of adverse effects can be increased when tizanidine is combined with clidinium.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when thiothixene is combined with triprolidine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with nefazodone.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with salicylamide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with lidocaine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with doxepin.


The risk or severity of adverse effects can be increased when physostigmine is combined with Varenicline.


The risk or severity of adverse effects can be increased when oxycodone is combined with pentazocine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when salicylamide is combined with estrone.


The risk or severity of adverse effects can be increased when propranolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with levorphanol.


The risk or severity of adverse effects can be increased when quetiapine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when MELPERONE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with ketorolac.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with nabumetone.


The risk or severity of adverse effects can be increased when quetiapine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when quetiapine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when gabapentin is combined with doxepin.


The risk or severity of adverse effects can be increased when flurazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Salsalate is combined with Propacetamol.


The risk or severity of adverse effects can be increased when methysergide is combined with Dronedarone.


The risk or severity of adverse effects can be increased when propofol is combined with chlormezanone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with fosinopril.


The risk or severity of adverse effects can be increased when betamethasone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when diltiazem is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when chlormezanone is combined with levodopa.


The risk or severity of adverse effects can be increased when betamethasone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when propofol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Asenapine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when morphine is combined with tetracaine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with glutethimide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with flunarizine.


The risk or severity of adverse effects can be increased when secobarbital is combined with clemastine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Naftifine is combined with betamethasone.


The risk or severity of adverse effects can be increased when butabarbital is combined with brotizolam.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when diclofenac is combined with desoximetasone.


The risk or severity of adverse effects can be increased when apomorphine is combined with phentolamine.


The risk or severity of adverse effects can be increased when isoflurane is combined with methocarbamol.


The risk or severity of adverse effects can be increased when apomorphine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when isoflurane is combined with triprolidine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when apomorphine is combined with furosemide.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with zotepine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with MELPERONE.


The risk or severity of adverse effects can be increased when oxybutynin is combined with hydromorphone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when dibucaine is combined with trazodone.


The risk or severity of adverse effects can be increased when tizanidine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with ifosfamide.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with acebutolol.


The risk or severity of adverse effects can be increased when Amrinone is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with captopril.


The risk or severity of adverse effects can be increased when valsartan is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with DESONIDE.


The risk or severity of adverse effects can be increased when trimipramine is combined with clidinium.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when valsartan is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when fosinopril is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Agomelatine is combined with clomipramine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Masoprocol.


The risk or severity of adverse effects can be increased when mechlorethamine is combined with clozapine.


The risk or severity of adverse effects can be increased when bromazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when trimipramine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when bromazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with triprolidine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with hydralazine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Metixene.


The risk or severity of adverse effects can be increased when protriptyline is combined with ritodrine.


The risk or severity of adverse effects can be increased when procyclidine is combined with topiramate.


The risk or severity of adverse effects can be increased when floctafenine is combined with tolmetin.


The risk or severity of adverse effects can be increased when Eletriptan is combined with rizatriptan.


The risk or severity of adverse effects can be increased when floctafenine is combined with haloperidol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when captopril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with triamcinolone.


The risk or severity of adverse effects can be increased when trimetrexate is combined with nimodipine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when halothane is combined with bumetanide.


The risk or severity of adverse effects can be increased when selegiline is combined with droxidopa.


The risk or severity of adverse effects can be increased when halothane is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when halothane is combined with quinapril.


The risk or severity of adverse effects can be increased when halothane is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with nimesulide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Flupentixol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Cangrelor is combined with salicylic acid.


The risk or severity of adverse effects can be increased when dicyclomine is combined with orphenadrine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when RUCAPARIB is combined with Flibanserin.


The risk or severity of adverse effects can be increased when norepinephrine is combined with terbutaline.


The risk or severity of adverse effects can be increased when Treprostinil is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when bromazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when Thioproperazine is combined with thiopental.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with chlorambucil.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with bleomycin.


The risk or severity of adverse effects can be increased when salicylamide is combined with Halobetasol.


The risk or severity of adverse effects can be increased when prilocaine is combined with citalopram.


The risk or severity of adverse effects can be increased when bromazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when salicylamide is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when naratriptan is combined with bromocriptine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Milnacipran.


The risk or severity of adverse effects can be increased when methysergide is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with felodipine.


The risk or severity of adverse effects can be increased when selegiline is combined with bromocriptine.


The risk or severity of adverse effects can be increased when ramipril is combined with salicylamide.


The risk or severity of adverse effects can be increased when oxazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when temazepam is combined with glutethimide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with pramipexole.


The risk or severity of adverse effects can be increased when nimesulide is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when butorphanol is combined with isoflurane.


The risk or severity of adverse effects can be increased when glutethimide is combined with clidinium.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Elbasvir.


The risk or severity of adverse effects can be increased when betaxolol is combined with atenolol.


The risk or severity of adverse effects can be increased when clotrimazole is combined with manidipine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when scopolamine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with loteprednol.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when temazepam is combined with dibucaine.


The risk or severity of adverse effects can be increased when propantheline is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when cilazapril is combined with carprofen.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with quetiapine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with clonazepam.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with promethazine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with furosemide.


The risk or severity of adverse effects can be increased when venlafaxine is combined with sumatriptan.


The risk or severity of adverse effects can be increased when valsartan is combined with papaverine.


The risk or severity of adverse effects can be increased when valsartan is combined with nifedipine.


The risk or severity of adverse effects can be increased when oxazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when midazolam is combined with Retigabine.


The risk or severity of adverse effects can be increased when gabapentin is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with bromocriptine.


The risk or severity of adverse effects can be increased when clozapine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Halazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with labetalol.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when pergolide is combined with norfloxacin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when leflunomide is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when promazine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with tiagabine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with cocaine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with zonisamide.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when pergolide is combined with nitrendipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with zopiclone.


The risk or severity of adverse effects can be increased when epinephrine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when captopril is combined with cilazapril.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with norfloxacin.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with Echothiophate.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with acebutolol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with oxymorphone.


The risk or severity of adverse effects can be increased when etizolam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with captopril.


The risk or severity of adverse effects can be increased when etizolam is combined with amoxapine.


The risk or severity of adverse effects can be increased when temazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with physostigmine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Tixocortol is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with bifonazole.


The risk or severity of adverse effects can be increased when Phenelzine is combined with periciazine.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when butabarbital is combined with tizanidine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with clidinium.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when dyclonine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with medrysone.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Amrinone.


The risk or severity of adverse effects can be increased when azelastine is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when butorphanol is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when clomipramine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when phenobarbital is combined with tetracaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when clomipramine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when procaine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when trazodone is combined with prazepam.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when procaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when chloroquine is combined with resveratrol.


The risk or severity of adverse effects can be increased when citalopram is combined with selegiline.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when ramipril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when ramipril is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when ramipril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when midazolam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with ambenonium.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with potassium ion.


The risk or severity of adverse effects can be increased when Dothiepin is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with acetylcholine.


The risk or severity of adverse effects can be increased when phentolamine is combined with sotalol.


The risk or severity of adverse effects can be increased when triazolam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Halazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Halazepam is combined with Melatonin.


The risk or severity of adverse effects can be increased when enflurane is combined with amisulpride.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when bifonazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when reserpine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when amoxapine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with diflorasone.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when propofol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when propofol is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with polythiazide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ruxolitinib.


The risk or severity of adverse effects can be increased when tropicamide is combined with methscopolamine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with loratadine.


The risk or severity of adverse effects can be increased when ramipril is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Tramadol is combined with topiramate.


The risk or severity of adverse effects can be increased when pentobarbital is combined with thiamylal.


The risk or severity of adverse effects can be increased when risperidone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when thioridazine is combined with Halazepam.


The risk or severity of adverse effects can be increased when risperidone is combined with maprotiline.


The risk or severity of adverse effects can be increased when thioridazine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when ketamine is combined with Normethadone.


The risk or severity of adverse effects can be increased when halothane is combined with HEROIN.


The risk or severity of adverse effects can be increased when diazepam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Alvimopan.


The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with betamethasone.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when morphine is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when sulconazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when morphine is combined with Asenapine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with clonidine.


The risk or severity of adverse effects can be increased when Tramadol is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when thiothixene is combined with Pipamperone.


The risk or severity of adverse effects can be increased when amcinonide is combined with edrophonium.


The risk or severity of adverse effects can be increased when flurazepam is combined with amobarbital.


The risk or severity of adverse effects can be increased when Tramadol is combined with baclofen.


The risk or severity of adverse effects can be increased when flurazepam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when timolol is combined with metolazone.


The risk or severity of adverse effects can be increased when flurazepam is combined with lithium ion.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when meprobamate is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with fenbufen.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with nefazodone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with benzocaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Halazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when Retigabine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when estazolam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when tretinoin is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when nalbuphine is combined with maprotiline.


The risk or severity of adverse effects can be increased when nalbuphine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when ramipril is combined with spironolactone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with felbamate.


The risk or severity of adverse effects can be increased when pentazocine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when trazodone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when diazepam is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with maprotiline.


The risk or severity of adverse effects can be increased when carprofen is combined with fluocinonide.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Tapentadol is combined with furazolidone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with quetiapine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when pentazocine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when pentazocine is combined with propofol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with topiramate.


The risk or severity of adverse effects can be increased when Tolcapone is combined with losartan.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when D-mannitol is combined with carvedilol.


The risk or severity of adverse effects can be increased when Tramadol is combined with oxprenolol.


The risk or severity of adverse effects can be increased when alprazolam is combined with procaine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with nicotine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Cevimeline.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Mometasone.


The risk or severity of adverse effects can be increased when Tramadol is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Tramadol is combined with prazepam.


The risk or severity of adverse effects can be increased when perphenazine is combined with meclizine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with propofol.


The risk or severity of adverse effects can be increased when reserpine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with suprofen.


The risk or severity of adverse effects can be increased when reserpine is combined with enalapril.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with periciazine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with fenbufen.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with morphine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Lofexidine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with bumetanide.


The risk or severity of adverse effects can be increased when etodolac is combined with difluprednate.


The risk or severity of adverse effects can be increased when thiopental is combined with meclizine.


The risk or severity of adverse effects can be increased when etodolac is combined with halcinonide.


The risk or severity of adverse effects can be increased when perphenazine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when nabumetone is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with SULFADOXINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfacytine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when tretinoin is combined with atenolol.


The risk or severity of adverse effects can be increased when venlafaxine is combined with clomipramine.


The risk or severity of adverse effects can be increased when celecoxib is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with ethosuximide.


The risk or severity of adverse effects can be increased when quetiapine is combined with halothane.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when CALCIUM GLUCONATE is combined with Calcium acetate.


The risk or severity of adverse effects can be increased when moclobemide is combined with Isometheptene.


The risk or severity of adverse effects can be increased when clozapine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when xylometazoline is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when quetiapine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Ruxolitinib is combined with clozapine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when nimodipine is combined with Riociguat.


The risk or severity of adverse effects can be increased when prazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Propiverine is combined with levorphanol.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when alprazolam is combined with baclofen.


The risk or severity of adverse effects can be increased when barnidipine is combined with reserpine.


The risk or severity of adverse effects can be increased when alprazolam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when diazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when meperidine is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when ritonavir is combined with metronidazole.


The risk or severity of adverse effects can be increased when fenoprofen is combined with carprofen.


The risk or severity of adverse effects can be increased when Torasemide is combined with spironolactone.


The risk or severity of adverse effects can be increased when desipramine is combined with isoetharine.


The risk or severity of adverse effects can be increased when felbamate is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with nadolol.


The risk or severity of adverse effects can be increased when Torasemide is combined with streptozocin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when propranolol is combined with lisinopril.


The risk or severity of adverse effects can be increased when buspirone is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when triamterene is combined with furosemide.


The risk or severity of adverse effects can be increased when paroxetine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with methocarbamol.


The risk or severity of adverse effects can be increased when midodrine is combined with benzphetamine.


The risk or severity of adverse effects can be increased when celecoxib is combined with Naftifine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with periciazine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when prazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with antipyrine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with metolazone.


The risk or severity of adverse effects can be increased when thiamylal is combined with amisulpride.


The risk or severity of adverse effects can be increased when fexofenadine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when butamben is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when thiopental is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with triamterene.


The risk or severity of adverse effects can be increased when thiopental is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when levorphanol is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when clorazepate is combined with clonazepam.


The risk or severity of adverse effects can be increased when clorazepate is combined with promethazine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when sumatriptan is combined with droperidol.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with metolazone.


The risk or severity of adverse effects can be increased when clorazepate is combined with Melatonin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when clozapine is combined with zopiclone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when clorazepate is combined with olanzapine.


The risk or severity of adverse effects can be increased when clozapine is combined with acebutolol.


The risk or severity of adverse effects can be increased when gabapentin is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Clobetasone.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Perospirone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when etodolac is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when metoclopramide is combined with prilocaine.


The risk or severity of adverse effects can be increased when thiothixene is combined with Butethal.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Perospirone.


The risk or severity of adverse effects can be increased when thiothixene is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with propoxyphene.


The risk or severity of adverse effects can be increased when rasagiline is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when rasagiline is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when rasagiline is combined with thiothixene.


The risk or severity of adverse effects can be increased when Lopinavir is combined with oxycodone.


The risk or severity of adverse effects can be increased when dantrolene is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with nimesulide.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with hydralazine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when olanzapine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when cabergoline is combined with etoposide.


The risk or severity of adverse effects can be increased when baclofen is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when selegiline is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when oxaliplatin is combined with clozapine.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with butorphanol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with etizolam.


The risk or severity of adverse effects can be increased when rizatriptan is combined with doxepin.


The risk or severity of adverse effects can be increased when selegiline is combined with sulpiride.


The risk or severity of adverse effects can be increased when ibuprofen is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with topiramate.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Perospirone.


The risk or severity of adverse effects can be increased when fenoprofen is combined with formestane.


The risk or severity of adverse effects can be increased when primidone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when trandolapril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when primidone is combined with amobarbital.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ganciclovir is combined with zidovudine.


The risk or severity of adverse effects can be increased when quazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when benzocaine is combined with desipramine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when benzocaine is combined with halothane.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with butamben.


The risk or severity of adverse effects can be increased when furosemide is combined with digitoxin.


The risk or severity of adverse effects can be increased when Isoconazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when zotepine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when nisoldipine is combined with papaverine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with nimesulide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when irbesartan is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Clofarabine is combined with morphine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when diflunisal is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when lithium ion is combined with baclofen.


The risk or severity of adverse effects can be increased when secobarbital is combined with Difenoxin.


The risk or severity of adverse effects can be increased when furosemide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when docetaxel is combined with Masoprocol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Belinostat.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with sulpiride.


The risk or severity of adverse effects can be increased when METYROSINE is combined with citalopram.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Rotigotine.


The risk or severity of adverse effects can be increased when perphenazine is combined with flunarizine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with donepezil.


The risk or severity of adverse effects can be increased when theophylline is combined with Indacaterol.


The risk or severity of adverse effects can be increased when enflurane is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Apremilast is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Apremilast is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when meprobamate is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when lorazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Miltefosine is combined with nicardipine.


The risk or severity of adverse effects can be increased when bifonazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when rapamycin is combined with isradipine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Pazopanib.


The risk or severity of adverse effects can be increased when HEROIN is combined with Difenoxin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when pimozide is combined with fexofenadine.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with warfarin.


The risk or severity of adverse effects can be increased when fenoprofen is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with propranolol.


The risk or severity of adverse effects can be increased when methyldopa is combined with penbutolol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with clonidine.


The risk or severity of adverse effects can be increased when lithium ion is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when methadone is combined with triprolidine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Nebivolol.


The risk or severity of adverse effects can be increased when lithium ion is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when lithium ion is combined with prazepam.


The risk or severity of adverse effects can be increased when promazine is combined with clonazepam.


The risk or severity of adverse effects can be increased when irbesartan is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when morphine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with loratadine.


The risk or severity of adverse effects can be increased when Pentolinium is combined with orphenadrine.


The risk or severity of adverse effects can be increased when methadone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with imipramine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with scopolamine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with D-mannitol.


The risk or severity of adverse effects can be increased when tolmetin is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Bretylium.


The risk or severity of adverse effects can be increased when fluvastatin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when paramethasone is combined with physostigmine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with dyclonine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with droperidol.


The risk or severity of adverse effects can be increased when cocaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when paramethasone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when resveratrol is combined with aspirin.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with captopril.


The risk or severity of adverse effects can be increased when cabergoline is combined with clozapine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with acebutolol.


The risk or severity of adverse effects can be increased when Fospropofol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Pipamperone is combined with metoprolol.


The risk or severity of adverse effects can be increased when fosinopril is combined with meperidine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with medrysone.


The risk or severity of adverse effects can be increased when diazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when diazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Halazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Clofarabine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when sulpiride is combined with dantrolene.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with epirizole.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with methyldopa.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when paramethasone is combined with galanthamine.


The risk or severity of adverse effects can be increased when paramethasone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when irbesartan is combined with atorvastatin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ranitidine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with tacrolimus.


The risk or severity of adverse effects can be increased when clemastine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when thiamylal is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when nicardipine is combined with felodipine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with quetiapine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when brimonidine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Tianeptine is combined with citalopram.


The risk or severity of adverse effects can be increased when ondansetron is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with bromazepam.


The risk or severity of adverse effects can be increased when nitric oxide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when methysergide is combined with irinotecan.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with meperidine.


The risk or severity of adverse effects can be increased when trazodone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when aspirin is combined with Propacetamol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with dantrolene.


The risk or severity of adverse effects can be increased when estrone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when lorazepam is combined with enflurane.


The risk or severity of adverse effects can be increased when lidocaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Melatonin is combined with protriptyline.


The risk or severity of adverse effects can be increased when Melatonin is combined with cetirizine.


The risk or severity of adverse effects can be increased when Propiverine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when methocarbamol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Bortezomib is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when diltiazem is combined with indapamide.


The risk or severity of adverse effects can be increased when nicardipine is combined with hydralazine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with HEROIN.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when nabumetone is combined with betamethasone.


The risk or severity of adverse effects can be increased when metoprolol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with pimozide.


The risk or severity of adverse effects can be increased when levorphanol is combined with Phenelzine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with lidocaine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with sertraline.


The risk or severity of adverse effects can be increased when Lofexidine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Lofexidine is combined with furosemide.


The risk or severity of adverse effects can be increased when sulindac is combined with formestane.


The risk or severity of adverse effects can be increased when Lurasidone is combined with clidinium.


The risk or severity of adverse effects can be increased when sulindac is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when iopamidol is combined with metformin.


The risk or severity of adverse effects can be increased when Naftifine is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with duloxetine.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with dimethyl sulfoxide.


The risk or severity of adverse effects can be increased when naratriptan is combined with promazine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with anastrozole.


The risk or severity of adverse effects can be increased when LISURIDE is combined with fluvastatin.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with medrysone.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when nimodipine is combined with benazepril.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with baclofen.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with levodopa.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when prednisone is combined with Demecarium.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when cetirizine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when nilvadipine is combined with thioridazine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Retigabine.


The risk or severity of adverse effects can be increased when paroxetine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when paramethasone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when fenofibrate is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when butalbital is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when lisinopril is combined with salicylamide.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with alclofenac.


The risk or severity of adverse effects can be increased when sulindac is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when isoflurane is combined with rasagiline.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with aspirin.


The risk or severity of adverse effects can be increased when estazolam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with methazolamide.


The risk or severity of adverse effects can be increased when Calcium acetate is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when trandolapril is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when trandolapril is combined with Metipranolol.


The risk or severity of adverse effects can be increased when fenbufen is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with leflunomide.


The risk or severity of adverse effects can be increased when fenbufen is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with doxepin.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Perospirone.


The risk or severity of adverse effects can be increased when citalopram is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Rotigotine.


The risk or severity of adverse effects can be increased when griseofulvin is combined with nimodipine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with zaleplon.


The risk or severity of adverse effects can be increased when morphine is combined with hydralazine.


The risk or severity of adverse effects can be increased when busulfan is combined with leflunomide.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when rasagiline is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when fludiazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when fludiazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Asunaprevir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when fludiazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Paliperidone is combined with primidone.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Mometasone.


The risk or severity of adverse effects can be increased when papaverine is combined with nifedipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with flunisolide.


The risk or severity of adverse effects can be increased when proparacaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when prilocaine is combined with cocaine.


The risk or severity of adverse effects can be increased when dorzolamide is combined with metformin.


The risk or severity of adverse effects can be increased when Etomidate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with Tramadol.


The risk or severity of adverse effects can be increased when miconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Prasugrel is combined with diflunisal.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with fenbufen.


The risk or severity of adverse effects can be increased when Propacetamol is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Tixocortol.


The risk or severity of adverse effects can be increased when cilazapril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when LISURIDE is combined with josamycin.


The risk or severity of adverse effects can be increased when Pramocaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Milnacipran.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when phenylephrine is combined with nylidrin.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with methazolamide.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Eplerenone.


The risk or severity of adverse effects can be increased when nicotinic acid is combined with pravastatin.


The risk or severity of adverse effects can be increased when pramipexole is combined with rasagiline.


The risk or severity of adverse effects can be increased when methylergonovine is combined with GLYCEROL PHENYLBUTYRATE.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with dipyridamole.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with mefloquine.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with pargyline.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Etomidate.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with losartan.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with bupivacaine.


The risk or severity of adverse effects can be increased when indomethacin is combined with halcinonide.


The risk or severity of adverse effects can be increased when metolazone is combined with methazolamide.


The risk or severity of adverse effects can be increased when thiothixene is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with hydromorphone.


The risk or severity of adverse effects can be increased when butabarbital is combined with clomipramine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with lithium ion.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when Nabilone is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when ethosuximide is combined with sertraline.


The risk or severity of adverse effects can be increased when Nabilone is combined with irbesartan.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with methylphenidate.


The risk or severity of adverse effects can be increased when hydralazine is combined with cilazapril.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with triprolidine.


The risk or severity of adverse effects can be increased when diazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when procaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when floctafenine is combined with Nepafenac.


The risk or severity of adverse effects can be increased when thiamylal is combined with Olopatadine.


The risk or severity of adverse effects can be increased when bepridil is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Pazopanib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Pizotifen.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with moclobemide.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Halazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when flurazepam is combined with thiothixene.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when flurazepam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when betaxolol is combined with trandolapril.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with methazolamide.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with triprolidine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Eplerenone.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when proparacaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Propacetamol.


The risk or severity of adverse effects can be increased when metoprolol is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with tizanidine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with furosemide.


The risk or severity of adverse effects can be increased when droperidol is combined with methylphenidate.


The risk or severity of adverse effects can be increased when quetiapine is combined with clidinium.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with promethazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with lidocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with clonazepam.


The risk or severity of adverse effects can be increased when nilvadipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with fluocinonide.


The risk or severity of adverse effects can be increased when bromazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when dibucaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when butamben is combined with amoxapine.


The risk or severity of adverse effects can be increased when dibucaine is combined with prilocaine.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when timolol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when sevoflurane is combined with amitriptyline.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with citalopram.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Tolcapone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with reserpine.


The risk or severity of adverse effects can be increased when meperidine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Perospirone.


The risk or severity of adverse effects can be increased when procyclidine is combined with oxybutynin.